INCIDENCE OF THROMBOEMBOLIC EVENTS IN PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Fernandes, A. C.
Meireles, S. R. [1 ]
Augusto, I. [1 ]
Aguas, L. [1 ]
Damasceno, M. [1 ]
机构：
[1] Hosp Sao Joao, Dept Med Oncol, Oporto, Portugal
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：525 / 526
页数：2
相关论文
共 50 条
  • [31] Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy
    Rouis, Houda
    Kamoun, Hela
    Rejeb, Hadhemi
    Ben Tkhayat, Achraf
    Smadhi, Hanen
    Greb, Dorra
    Ben Abdelghaffar, Hajer
    Akrout, Ines
    Hassene, Hela
    Fekih, Leila
    Megdiche, Mohamed Lamine
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [32] REDUCED NATURAL CYTOTOXIC-CELL ACTIVITY IN PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY AND IN MICE TREATED WITH CISPLATIN
    POWELL, CB
    MUTCH, DG
    KAO, MS
    COLLINS, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 79 (03): : 424 - 429
  • [33] Thromboembolic events (TE) during treatment with cisplatin-based chemotherapy (CBCT) in metastatic testicular germ-cell cancer (TC)
    Haugnes, H. S. Sagstuen
    Negaard, H. F. S.
    Jensvoll, H.
    Wilsgaard, T.
    Tandstad, T.
    Solberg, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S600 - S600
  • [34] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    M B Polee
    W C J Hop
    T C Kok
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2003, 89 : 2045 - 2050
  • [36] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [37] Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy
    Argiris, A
    Li, Y
    Murphy, BA
    Langer, CJ
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 262 - 268
  • [38] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    Polee, MB
    Hop, WCJ
    Kok, TC
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tillanus, HW
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2045 - 2050
  • [39] Vascular fi ngerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events
    Meuleman, A. T.
    Volders, E. L. D.
    Lubberts, S.
    Kerst, J. M.
    Wymenga, A. N. M.
    Aarts, M. J. B.
    Goncalves, M. B.
    Lefrandt, J. D.
    Steursma, G.
    Meijer, J.
    Nuver, J.
    Gietema, J. A.
    ESMO OPEN, 2024, 9 (07)
  • [40] INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY
    Patterson, Laurel
    Pandya, Rishikesh
    Margel, David
    Hotte, Sebastien J.
    Shayegan, Bobby
    Mukherjee, Som D.
    Pinthus, Jehonathan H.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E590 - E591
12345